Amalgamated Bank Reduces Position in Covetrus, Inc. (NASDAQ:CVET)
Amalgamated Bank Reduces Position in Covetrus, Inc. (NASDAQ:CVET)
Amalgamated Bank decreased its holdings in shares of Covetrus, Inc. (NASDAQ:CVET – Get Rating) by 5.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 46,361 shares of the company's stock after selling 2,442 shares during the quarter. Amalgamated Bank's holdings in Covetrus were worth $778,000 as of its most recent SEC filing.
根據合併銀行提交給美國證券交易委員會的最新Form 13F文件，該行在第一季度減持了CovetrusInc.(納斯達克代碼：CVET-GET評級)的股票5.0%。該機構投資者在本季度出售了2,442股後，持有該公司46,361股股票。截至最近提交給美國證券交易委員會的文件，合併銀行持有的Covetrus股份價值77.8萬美元。
Other large investors have also modified their holdings of the company. Point72 Hong Kong Ltd purchased a new stake in shares of Covetrus during the first quarter worth $43,000. Aaron Wealth Advisors LLC purchased a new stake in shares of Covetrus during the first quarter worth $339,000. Crossmark Global Holdings Inc. acquired a new position in shares of Covetrus during the 1st quarter valued at about $170,000. Nisa Investment Advisors LLC boosted its position in shares of Covetrus by 23.4% during the 1st quarter. Nisa Investment Advisors LLC now owns 11,080 shares of the company's stock valued at $186,000 after acquiring an additional 2,100 shares during the last quarter. Finally, American Trust acquired a new position in shares of Covetrus during the 1st quarter valued at about $188,000. Hedge funds and other institutional investors own 92.20% of the company's stock.
其他大型投資者也調整了對該公司的持股。Point72 Hong Kong Ltd在第一季度購買了價值43,000美元的Covetrus新股。Aaron Wealth Advisors LLC在第一季度購買了價值33.9萬美元的Covetrus新股。Crossmark Global Holdings Inc.在第一季度收購了Covetrus的新頭寸，價值約17萬美元。NISA Investment Advisors LLC在第一季度將其在Covetrus股票的頭寸增加了23.4%。NISA Investment Advisors LLC現在擁有11,080股該公司股票，價值18.6萬美元，該公司在上個季度又收購了2,100股。最後，美國信託在第一季度收購了Covetrus的新頭寸，價值約為188,000美元。對衝基金和其他機構投資者持有該公司92.20%的股票。
Analyst Ratings Changes
分析師評級發生變化
Several brokerages have recently weighed in on CVET. TheStreet raised shares of Covetrus from a "d+" rating to a "c-" rating in a research report on Wednesday. Stifel Nicolaus cut shares of Covetrus from a "buy" rating to a "hold" rating and set a $22.00 price target on the stock. in a research report on Monday, June 13th. One analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $21.40.
幾家券商最近也加入了CVeT的行列。華爾街在週三的一份研究報告中將Covetrus的股票評級從“d+”上調至“c-”。Stifel Nicolaus將Covetrus的股票評級從買入下調至持有，併為該股設定了22.00美元的目標價。在6月13日星期一的一份研究報告中。一名分析師對該股的評級為賣出，五名分析師對該公司的評級為持有。根據MarketBeat.com的數據，該公司目前的平均評級為持有，平均目標價為21.40美元。
Insider Buying and Selling
內幕買賣
Covetrus Trading Down 0.1 %
椰子交易下跌0.1%
NASDAQ CVET opened at $20.88 on Friday. The firm's 50-day moving average is $20.83 and its two-hundred day moving average is $19.09. Covetrus, Inc. has a 12 month low of $13.39 and a 12 month high of $21.20. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.88 and a quick ratio of 1.08. The stock has a market capitalization of $2.93 billion, a P/E ratio of -208.80 and a beta of 1.63.
納斯達克CVET上週五開盤報20.88美元。該公司的50日移動均線切入位為20.83美元，200日移動均線切入位為19.09美元。Covetrus，Inc.的12個月低點為13.39美元，12個月高位為21.20美元。該公司的債務權益比為0.65，流動比率為1.88，速動比率為1.08。該股市值29.3億美元，市盈率為-208.80，貝塔係數為1.63.
Covetrus (NASDAQ:CVET – Get Rating) last issued its quarterly earnings results on Thursday, August 4th. The company reported $0.20 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.20. The company had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.23 billion. Covetrus had a negative net margin of 0.28% and a positive return on equity of 6.83%. On average, sell-side analysts anticipate that Covetrus, Inc. will post 0.84 earnings per share for the current year.
納斯達克(股票代碼：CVET-GET Rating)最近一次發佈季度收益報告是在8月4日(星期四)。該公司公佈本季度每股收益(EPS)為0.20美元，超過分析師普遍預期的0.20美元。該公司本季度營收為12.2億美元，而分析師預期為12.3億美元。Covetrus的淨利潤率為負0.28%，股本回報率為正6.83%。賣方分析師平均預計，Covetrus，Inc.本年度每股收益將為0.84美元。
About Covetrus
關於Covetrus
(Get Rating)
(獲取評級)
Covetrus, Inc, together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers.
Covetrus，Inc.及其子公司是一家動物保健技術和服務公司。它從事向批發和零售客户銷售動物健康消耗品，包括專利和Covetrus品牌產品、小型設備、實驗室產品、大型設備、設備維修服務、品牌和仿製藥、疫苗、外科產品、診斷測試、感染控制產品、寄生蟲藥以及維生素和補充劑。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Covetrus (CVET)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Declining Profits Challenge the CarMax Value Proposition
- Thor Industries Hammers Out A Bottom
- 免費獲取StockNews.com關於Covetrus的研究報告(CVeT)
- 電動汽車電池製造商Freyr將在全球大舉擴張
- MarketBeat：回顧一週9/26-9/30
- 這是買入美光科技的難忘時刻
- 利潤下降對CarMax價值主張的挑戰
- 雷神工業走出谷底
Want to see what other hedge funds are holding CVET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Covetrus, Inc. (NASDAQ:CVET – Get Rating).
想看看還有哪些對衝基金持有CVeT嗎？訪問HoldingsChannel.com獲取Covetrus，Inc.(納斯達克代碼：CVeT-GET Rating)的最新13F備案文件和內幕交易信息。
Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.
接受《椰子日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Covetrus和相關公司的最新新聞和分析師評級的每日簡要摘要。